Pantoprazole Sodium Tablet, Delayed Release
Product Images NDC 85509-1636

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pantoprazole Sodium (NDC 85509-1636). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Phoenix Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (16336)

Text panel for Pantoprazole Sodium Delayed-Release Tablets USP 20 mg, showing NDC 85509-1636-6. The panel lists contents per tablet, dosage guidance to not split or crush tablets, storage conditions, and pharmacist instructions to dispense a medication guide. It states 60 tablets per container, prescription only, manufactured by Amneal Pharmaceuticals Pvt. Ltd., repackaged by PHOENIX RX LLC in Hatboro, PA, and expiration date July 10, 2026.*

FDA Label Image

1 (Pantoprazole Sodium Delayed Release Tablets Usp 1)

Chemical structure of pantoprazole including indications of sodium ion (Na+) and 1.5 molecules of water (H2O). The diagram shows the molecular connectivity and arrangement of atoms characteristic of pantoprazole's active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.